Healthcare provider profile · identity verified

Michael J Kordus, MD

Family Practice · WHITE CITY, OR · NPI 1013970540

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	373	64
Atorvastatin Calcium	Atorvastatin Calcium	293	82
Levothyroxine Sodium	Levothyroxine Sodium	278	74
Gabapentin	Gabapentin	201	60
Omeprazole	Omeprazole	170	52
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	163	24
Albuterol Sulfate Hfa	Albuterol Sulfate	154	48
Amlodipine Besylate	Amlodipine Besylate	150	47
Metoprolol Succinate	Metoprolol Succinate	144	38
Losartan Potassium	Losartan Potassium	126	45
Rosuvastatin Calcium	Rosuvastatin Calcium	126	40
Duloxetine Hcl	Duloxetine Hcl	125	30
Metformin Hcl Er	Metformin Hcl	110	29
Lisinopril	Lisinopril	99	32
Simvastatin	Simvastatin	97	23
Hydrochlorothiazide	Hydrochlorothiazide	88	24
Potassium Chloride	Potassium Chloride	88	31
Eliquis	Apixaban	86	16
Trazodone Hcl	Trazodone Hcl	84	31
Furosemide	Furosemide	80	29
Tamsulosin Hcl	Tamsulosin Hcl	77	28
Fluticasone Propionate	Fluticasone Propionate	75	24
Oxycodone Hcl	Oxycodone Hcl	68	11
Pantoprazole Sodium	Pantoprazole Sodium	64	21
Carvedilol	Carvedilol	63	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	62	21
Clopidogrel	Clopidogrel Bisulfate	59	16
Tramadol Hcl	Tramadol Hcl	59	16
Pregabalin	Pregabalin	57	13
Metoprolol Tartrate	Metoprolol Tartrate	50	18
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	44	suppressed
Ezetimibe	Ezetimibe	42	13
Glimepiride	Glimepiride	41	11
Lorazepam	Lorazepam	41	suppressed
Topiramate	Topiramate	41	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	40	11
Montelukast Sodium	Montelukast Sodium	39	suppressed
Ropinirole Hcl	Ropinirole Hcl	37	12
Cephalexin	Cephalexin	36	27
Metformin Hcl	Metformin Hcl	36	14
Sertraline Hcl	Sertraline Hcl	36	11
Zolpidem Tartrate	Zolpidem Tartrate	36	14
Quetiapine Fumarate	Quetiapine Fumarate	35	12
Tizanidine Hcl	Tizanidine Hcl	35	15
Pioglitazone Hcl	Pioglitazone Hcl	34	13
Famotidine	Famotidine	33	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	32	suppressed
Ozempic	Semaglutide	32	suppressed
Xarelto	Rivaroxaban	32	suppressed
Citalopram Hbr	Citalopram Hydrobromide	31	12
Ibuprofen	Ibuprofen	30	suppressed
Clonidine Hcl	Clonidine Hcl	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	14
Ondansetron Odt	Ondansetron	28	12
Allopurinol	Allopurinol	26	suppressed
Celecoxib	Celecoxib	25	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Olanzapine	Olanzapine	24	suppressed
Baclofen	Baclofen	23	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Estradiol	Estradiol	22	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Terazosin Hcl	Terazosin Hcl	21	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Jardiance	Empagliflozin	20	suppressed
Methylprednisolone	Methylprednisolone	20	16
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	18	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Clonazepam	Clonazepam	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	15
Escitalopram Oxalate	Escitalopram Oxalate	17	suppressed
Finasteride	Finasteride	17	suppressed
Linzess	Linaclotide	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Atenolol	Atenolol	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Digoxin	Digoxin	15	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Latanoprost	Latanoprost	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	11
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Azithromycin	Azithromycin	14	13
Ciclopirox	Ciclopirox	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Atrovent Hfa	Ipratropium Bromide	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Lidocaine-Prilocaine	Lidocaine/Prilocaine	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Diazepam	Diazepam	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Insulin Aspart Flexpen	Insulin Aspart	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Torsemide	Torsemide	12	suppressed
Tramadol Hcl Er	Tramadol Hcl	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed
Pentoxifylline	Pentoxifylline	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error